apaz.healthology.com/faculty_minibio.asp?f=hiv&d=butche -
[Cached Version]
Published on: 4/5/2002
Last Visited: 12/16/2002
David L. Butcher, M.D.
Metropolitan Community Health Services
...
DAVID L. BUTCHER, MD: People feel like they can't go out in public without someone looking at them that's familiar with HIV disease and treatment and saying, "Aha, there's someone with HIV."
ANNOUNCER: In addition to unusual weight gain and loss, patients with lipodystrophy often have elevated blood levels of cholesterol and triglycerides.And those changes can be life threatening.
...
DAVID L. BUTCHER, MD: The cause of lipodystrophy is still unknown, to be very brief and very blunt.Now, there are certain aspects of the syndrome that are clearly related to the drugs that we use.
ANNOUNCER: Protease inhibitors, one of the important categories of HIV medication, have been linked to some aspects of lipodystrophy, especially the elevated levels of cholesterol and triglycerides.
Other HIV medications have also been associated with the condition.
...
David L. Butcher, M.D.Metropolitan Community Health Services
...
>> Webcasts with David L. Butcher, M.D.
David L. Butcher, M.D., is currently the Medical Director at Metropolitan Community Health Services and Associate Clinical Professor of Medicine at East Carolina University.Since graduating from the University of Kansas School of Medicine, he has worked extensively in HIV clinical research, primary care, and education, lecturing both nationally and internationally.Dr. Butcher is a member of the Board of Directors of the American Academy of HIV Medicine and previous member of the Maryland Governor's Task Force to Study Health Care Needs of Inmates from Correctional Institutions.He also serves as a consultant for Human Resources and Services Administration (HRSA) regarding HIV care and the Ryan White Care Act.Current areas of interest and research include adherence, addictions, and Clinical Trials of new HIV therapies.
Webcasts with David L. Butcher, M.D.:
Lipodystrophy in HIV Disease